PACS Group, Inc. (NYSE:PACS) Stock Has Average Price Target of $61.33

07 Nov 2026, 10:10 by Michael Walen · The Markets Daily

Shares of PACS Group, Inc. (NYSE:PACS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $61.33.

Several equities analysts have commented on PACS shares. JPMorgan Chase & Co. upped their price objective on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a report on Friday, September 4th. Royal Bank Of Canada increased their price target on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a report on Thursday, August 6th. Truist Financial reaffirmed a “buy” rating and set a $65.00 price objective (up from $62.00) on shares of PACS Group in a report on Thursday. Oppenheimer boosted their price target on PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. Finally, Wall Street Zen cut PACS Group from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 8th.

Read Our Latest Research Report on PACS Group

Key PACS Group News

Here are the key news stories impacting PACS Group this week:

Positive Sentiment: Quarterly results beat expectations and outlook rose. PACS reported Q3 EPS of $0.63 and revenue of $1.50 billion, topping estimates; adjusted EBITDA increased 33.6%. Management raised its 2026 revenue forecast to $5.95–$6.05 billion and adjusted EBITDA outlook to $685–$695 million. Q3 earnings coverage Raised 2026 outlook
Positive Sentiment: Expansion and facility ramp-ups may support continued growth. Recent acquisitions in Florida and Texas, along with the Eduro deal, add about 8,400 beds. Company leaders cited occupancy near 90%, while newer facilities mature and move toward higher occupancy and patient acuity. Acquisitions and results Occupancy and acquisitions
Positive Sentiment: Analysts raised targets and maintained bullish ratings. Truist lifted its target to $65 and kept Buy; Stephens raised its target to $64 with an Overweight rating. UBS also raised its target to $67 and maintained Buy. Truist target update Stephens forecast
Negative Sentiment: Executives and a director disclosed stock sales. CEO Jason Murray and director Mark Hancock sold shares, as did the CAO. The transactions were made under pre-arranged Rule 10b5-1 plans, and the CEO and director retained substantial holdings, which may temper concerns. Director sale CEO sale

Insiders Place Their Bets

In other PACS Group news, CEO Jason Murray sold 167,434 shares of PACS Group stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $50.24, for a total transaction of $8,411,884.16. Following the completion of the sale, the chief executive officer owned 53,954,101 shares of the company’s stock, valued at approximately $2,710,654,034.24. The trade was a 0.31% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Mark Hancock sold 186,696 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The shares were sold at an average price of $50.45, for a total value of $9,418,813.20. Following the completion of the sale, the director owned 53,318,884 shares in the company, valued at $2,689,937,697.80. The trade was a 0.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,762,431 shares of company stock worth $80,686,053. 70.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On PACS Group

A number of large investors have recently made changes to their positions in PACS. Eurizon Capital SGR S.p.A. purchased a new stake in shares of PACS Group during the third quarter worth $34,000. Fulcrum Asset Management LLP increased its holdings in shares of PACS Group by 244.8% in the 3rd quarter. Fulcrum Asset Management LLP now owns 11,014 shares of the company’s stock valued at $465,000 after acquiring an additional 7,820 shares during the last quarter. Vise Technologies Inc. boosted its stake in PACS Group by 40.6% during the third quarter. Vise Technologies Inc. now owns 7,209 shares of the company’s stock valued at $300,000 after buying an additional 2,081 shares in the last quarter. State of Wyoming grew its holdings in shares of PACS Group by 11.9% during the 3rd quarter. State of Wyoming now owns 10,551 shares of the company’s stock valued at $438,000 after acquiring an additional 1,119 shares in the last quarter. Finally, Smith Group Asset Management LLC raised its position in shares of PACS Group by 1.3% during the third quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock valued at $1,025,000 after buying an additional 320 shares during the last quarter.

PACS Group Stock Down 1.0%

Shares of PACS Group stock opened at $49.68 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.91 and a current ratio of 0.91. The company has a market cap of $7.86 billion, a P/E ratio of 28.07, a PEG ratio of 1.42 and a beta of -0.14. The firm has a fifty day moving average of $44.64 and a two-hundred day moving average of $40.03. PACS Group has a one year low of $10.31 and a one year high of $51.68.

PACS Group (NYSE:PACS – Get Free Report) last issued its earnings results on Tuesday, November 3rd. The company reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.05. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. The firm had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.46 billion. On average, analysts forecast that PACS Group will post 2.13 earnings per share for the current year.

About PACS Group

(Get Free Report)

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.